发布求助
文献互助 智能选刊 最新文献

Journal of Clinical Psychopharmacology最新文献

筛选
英文 中文
Question: Do You Have Suggestions for Managing a Patient With Bipolar II Disorder, Binge Eating Disorder, and Obesity Who Stops Medications Fearing Weight Gain? 问：患有双相情感障碍 II、暴食症和肥胖症的患者因担心体重增加而停止服药，您对如何管理这类患者有什么建议？
IF 2.9 3区 医学
Journal of Clinical Psychopharmacology Pub Date : 2024-11-01 Epub Date: 2024-10-24 DOI: 10.1097/JCP.0000000000001929
Susan L McElroy
{"title":"Question: Do You Have Suggestions for Managing a Patient With Bipolar II Disorder, Binge Eating Disorder, and Obesity Who Stops Medications Fearing Weight Gain?","authors":"Susan L McElroy","doi":"10.1097/JCP.0000000000001929","DOIUrl":"10.1097/JCP.0000000000001929","url":null,"abstract":"","PeriodicalId":15455,"journal":{"name":"Journal of Clinical Psychopharmacology","volume":" ","pages":"601-602"},"PeriodicalIF":2.9,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142501235","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Lumbosacral Plexopathy in Clozapine Overdose: A Case Report. 氯氮平过量引起的腰骶部神经丛病：病例报告。
IF 2.9 3区 医学
Journal of Clinical Psychopharmacology Pub Date : 2024-11-01 Epub Date: 2024-10-14 DOI: 10.1097/JCP.0000000000001914
Tugba Ozudogru Celik
{"title":"Lumbosacral Plexopathy in Clozapine Overdose: A Case Report.","authors":"Tugba Ozudogru Celik","doi":"10.1097/JCP.0000000000001914","DOIUrl":"10.1097/JCP.0000000000001914","url":null,"abstract":"","PeriodicalId":15455,"journal":{"name":"Journal of Clinical Psychopharmacology","volume":" ","pages":"586-589"},"PeriodicalIF":2.9,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142406452","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Subject Index 2024. 主题索引2024。
IF 2.9 3区 医学
Journal of Clinical Psychopharmacology Pub Date : 2024-11-01 DOI: 10.1097/JCP.0000000000001932
{"title":"Subject Index 2024.","authors":"","doi":"10.1097/JCP.0000000000001932","DOIUrl":"https://doi.org/10.1097/JCP.0000000000001932","url":null,"abstract":"","PeriodicalId":15455,"journal":{"name":"Journal of Clinical Psychopharmacology","volume":"44 6","pages":"606-615"},"PeriodicalIF":2.9,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143006203","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Mechanisms of Drug-Associated Burning Mouth Syndrome. 药物相关灼口综合征的机理。
IF 2.9 3区 医学
Journal of Clinical Psychopharmacology Pub Date : 2024-09-11 DOI: 10.1097/jcp.0000000000001915
Takahiko Nagamine
{"title":"Mechanisms of Drug-Associated Burning Mouth Syndrome.","authors":"Takahiko Nagamine","doi":"10.1097/jcp.0000000000001915","DOIUrl":"https://doi.org/10.1097/jcp.0000000000001915","url":null,"abstract":"","PeriodicalId":15455,"journal":{"name":"Journal of Clinical Psychopharmacology","volume":"100 1","pages":""},"PeriodicalIF":2.9,"publicationDate":"2024-09-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142192195","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A Case Series: Psychotic Disorder Associated With Gummies Containing Delta-8-Tetrahydrocannabinol. 病例系列：与含有δ-8-四氢大麻酚的软糖有关的精神紊乱。
IF 2.9 3区 医学
Journal of Clinical Psychopharmacology Pub Date : 2024-09-01 Epub Date: 2024-07-16 DOI: 10.1097/JCP.0000000000001884
David R Spiegel, Jason Bard, Megan Ralston, William Crafton, Alim Osman, Kallen Hager, Pavan Suryadevara
{"title":"A Case Series: Psychotic Disorder Associated With Gummies Containing Delta-8-Tetrahydrocannabinol.","authors":"David R Spiegel, Jason Bard, Megan Ralston, William Crafton, Alim Osman, Kallen Hager, Pavan Suryadevara","doi":"10.1097/JCP.0000000000001884","DOIUrl":"10.1097/JCP.0000000000001884","url":null,"abstract":"","PeriodicalId":15455,"journal":{"name":"Journal of Clinical Psychopharmacology","volume":" ","pages":"512-514"},"PeriodicalIF":2.9,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141620087","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Modafinil Use in an Adolescent With Major Depressive Disorder. 青少年重度抑郁症患者使用莫达非尼。
IF 2.9 3区 医学
Journal of Clinical Psychopharmacology Pub Date : 2024-09-01 Epub Date: 2024-07-16 DOI: 10.1097/JCP.0000000000001893
Ecem Özer Çakır, Oğuz Bilal Karakuş, İbrahim Adak
{"title":"Modafinil Use in an Adolescent With Major Depressive Disorder.","authors":"Ecem Özer Çakır, Oğuz Bilal Karakuş, İbrahim Adak","doi":"10.1097/JCP.0000000000001893","DOIUrl":"10.1097/JCP.0000000000001893","url":null,"abstract":"","PeriodicalId":15455,"journal":{"name":"Journal of Clinical Psychopharmacology","volume":" ","pages":"514-516"},"PeriodicalIF":2.9,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141620091","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Substance-Related Withdrawal Catatonia in Co-occurring Disorders: Lessons Learned From Two Case Reports. 并发症中与药物相关的戒断紧张症：从两份病例报告中汲取的教训。
IF 2.9 3区 医学
Journal of Clinical Psychopharmacology Pub Date : 2024-09-01 Epub Date: 2024-08-22 DOI: 10.1097/JCP.0000000000001886
Reza Rafizadeh, Ataa Azarbar, Lukas Hestvik, Jennifer Clune, Nickie Mathew
{"title":"Substance-Related Withdrawal Catatonia in Co-occurring Disorders: Lessons Learned From Two Case Reports.","authors":"Reza Rafizadeh, Ataa Azarbar, Lukas Hestvik, Jennifer Clune, Nickie Mathew","doi":"10.1097/JCP.0000000000001886","DOIUrl":"10.1097/JCP.0000000000001886","url":null,"abstract":"","PeriodicalId":15455,"journal":{"name":"Journal of Clinical Psychopharmacology","volume":" ","pages":"524-527"},"PeriodicalIF":2.9,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142035997","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A Case Report and Mini Review on Clozapine Treatment During Chemotherapy: Is it Possible to Manage Neutropenia Successfully With Secondary G-CSF? 关于化疗期间氯氮平治疗的病例报告和小型综述：二次 G-CSF 能否成功控制中性粒细胞减少症？
IF 2.9 3区 医学
Journal of Clinical Psychopharmacology Pub Date : 2024-09-01 Epub Date: 2024-08-22 DOI: 10.1097/JCP.0000000000001900
Selvi Ceran, Beren Özel, Ali Ercan Altinoz, Nurhak Çağatay Birer, Arzu Oğuz
{"title":"A Case Report and Mini Review on Clozapine Treatment During Chemotherapy: Is it Possible to Manage Neutropenia Successfully With Secondary G-CSF?","authors":"Selvi Ceran, Beren Özel, Ali Ercan Altinoz, Nurhak Çağatay Birer, Arzu Oğuz","doi":"10.1097/JCP.0000000000001900","DOIUrl":"10.1097/JCP.0000000000001900","url":null,"abstract":"","PeriodicalId":15455,"journal":{"name":"Journal of Clinical Psychopharmacology","volume":" ","pages":"522-524"},"PeriodicalIF":2.9,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142035991","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
High-Dose Propranolol for Severe and Chronic Aggression in Autism Spectrum Disorder: A Pilot, Double-Blind, Placebo-Controlled, Randomized Crossover Study. 大剂量普萘洛尔治疗自闭症谱系障碍患者的严重和慢性攻击行为：一项试验性、双盲、安慰剂对照、随机交叉研究。
IF 2.9 3区 医学
Journal of Clinical Psychopharmacology Pub Date : 2024-09-01 Epub Date: 2024-08-23 DOI: 10.1097/JCP.0000000000001895
Eric B London, Barbie L Zimmerman-Bier, J Helen Yoo, Joseph W Gaffney
{"title":"High-Dose Propranolol for Severe and Chronic Aggression in Autism Spectrum Disorder: A Pilot, Double-Blind, Placebo-Controlled, Randomized Crossover Study.","authors":"Eric B London, Barbie L Zimmerman-Bier, J Helen Yoo, Joseph W Gaffney","doi":"10.1097/JCP.0000000000001895","DOIUrl":"10.1097/JCP.0000000000001895","url":null,"abstract":"<p><strong>Background: </strong>Despite the use of behavioral interventions and psychotropic medications, many individuals with autism spectrum disorder (ASD) who engage in severe aggression remain refractory to conventional treatment. Propranolol, a beta-blocker, has accumulated much anecdotal evidence as a promising option. However, well-designed studies are rare, and the apprehension about cardiovascular side effects from large doses continues to exist.</p><p><strong>Purpose: </strong>The aims of this study were (1) to demonstrate the feasibility of treating aggression with high-dose propranolol using telehealth study visits and (2) to document cardiac safety.</p><p><strong>Methods: </strong>This study utilized a randomized, double-blind, placebo-controlled, crossover design. Dosing was titrated up in a flexible but stepwise fashion until therapeutic response was obtained or up to 200 mg tid. Following washout, those who were assigned propranolol were crossed over to placebo and vice versa. Six participants between the ages 12-19 participated. The primary outcome measures were the final Clinical Global Impression Improvement Scale (CGI-I) and the Aberrant Behavior Checklist-Community Irritability (ABC-C/I) scores at 200 mg tid.</p><p><strong>Results: </strong>The CGI-I indicated a 50% reduction in symptoms in the propranolol phase, while the ABC-I indicated a 37% reduction in comparison to placebo. The effect sizes ( r ) for the CGI-I and the ABC-C/I were large, -0.74 and -0.64, respectively. The average blood pressure was 122/68 during the placebo phase and 109/72 during the propranolol phase. All Holter monitor exams were unremarkable.</p><p><strong>Conclusion: </strong>These results suggest that propranolol is an effective option in decreasing aggression in individuals with ASD. As this was a small study, a larger clinical trial is needed.</p>","PeriodicalId":15455,"journal":{"name":"Journal of Clinical Psychopharmacology","volume":" ","pages":"462-467"},"PeriodicalIF":2.9,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11460740/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142035992","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Clozapine-Associated Eosinophilia at a Movement Disorders Clinic. 运动障碍诊所的氯氮平相关嗜酸性粒细胞增多症。
IF 2.9 3区 医学
Journal of Clinical Psychopharmacology Pub Date : 2024-09-01 Epub Date: 2024-08-09 DOI: 10.1097/JCP.0000000000001902
Nahid Mohammadzadeh, Biju Gopalakrishnan, Joseph H Friedman
{"title":"Clozapine-Associated Eosinophilia at a Movement Disorders Clinic.","authors":"Nahid Mohammadzadeh, Biju Gopalakrishnan, Joseph H Friedman","doi":"10.1097/JCP.0000000000001902","DOIUrl":"10.1097/JCP.0000000000001902","url":null,"abstract":"","PeriodicalId":15455,"journal":{"name":"Journal of Clinical Psychopharmacology","volume":"44 5","pages":"509-511"},"PeriodicalIF":2.9,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142154223","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
首页 上一页
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整，为了账户安全，请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们：info@booksci.cn Book学术提供免费学术资源搜索服务，方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号：481959085
Book学术官方微信